Avalo Therapeutics Cash Flow Statement (2014-2026) | AVTX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
0.08M-0.07M-9.96M-8.19M-5.23M-8.17M-121.29M98.46M23.04M-35.34M-13.15M-20.77M-30.62M-13.72M-19.63M-36.36M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
1.76M1.89M5.31M0.67M0.73M0.84M0.85M0.89M0.95M0.78M0.63M-0.63M0.51M8.60M-8.60M0.78M5.30M
Deferred Taxes (Quarter)
0.01M-0.06M0.01M0.01M0.01M0.01M0.01M0.01M0.01M-0.01M0.01M0.01M-0.01M0.11M0.01M0.02M0.01M0.13M0.01M0.02M
Gains from Investment Securities (Quarter)
1,700.00M79.28M-112.05M-36.02M135.57M6.57M
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-16.29M-17.10M-16.07M-12.47M5.73M-3.94M-10.05M-11.03M-6.84M-2.77M-6.20M-16.28M-11.53M-15.04M-9.46M-11.34M-16.41M-14.29M-17.70M-20.00M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.34M0.35M0.35M0.34M0.35M0.35M0.35M0.35M0.90M0.15M0.35M0.20M0.11M0.42M
Depreciation & Amortization (CF) (Quarter)
0.46M0.29M0.07M0.03M0.03M0.04M0.03M0.04M0.04M0.04M0.03M0.03M0.03M0.07M0.14M0.13M0.06M0.02M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
-2.69M-0.38M-0.12M-0.39M-0.54M0.04M-0.04M
Change in Inventory (Quarter)
-0.00M0.02M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.02M
Change in Account Payables (Quarter)
1.32M-0.20M0.39M-1.59M-0.72M1.44M2.68M-4.81M0.04M-0.34M0.47M-0.26M1.16M-1.53M0.40M1.69M-1.89M-0.34M0.22M2.99M
Change in Accured Expenses (Quarter)
-2.31M0.65M-2.29M-1.25M0.39M-0.49M-4.94M-0.69M-2.46M-0.96M-1.65M0.40M-0.86M1.00M-1.70M1.99M1.02M5.35M-1.50M6.62M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-0.34M0.96M0.31M-0.80M-0.77M0.17M0.34M-0.49M-0.20M-0.10M0.05M1.44M1.78M-0.40M-2.49M0.07M0.24M4.77M-0.23M0.92M
Investing Activities
Capital Expenditures (Quarter)
1.98M-1.00M0.06M-0.06M0.10M0.16M
Sales of Property, Plant and Equipment (Quarter)
0.03M
Acquisitions (Quarter)
0.36M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
21.50M25.50M23.88M
Cash from Investing Activities (Quarter)
-0.08M-0.01M-0.06M-0.04M-0.13M0.36M-70.86M-13.26M2.40M25.50M-329.93M
Financing Activities
Other financing activities (Quarter)
0.16M0.05M0.07M-0.07M108.10M7.53M142.70M0.04M-0.04M2.18M5.23M
Cash from Financing Activities (Quarter)
47.64M0.08M-14.78M0.08M13.75M0.60M10.70M0.00M108.61M-0.47M67.71M-0.47M14.37M0.69M1.40M410.21M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
25.94M
Additional items
Change in Cash (Quarter)
31.27M-17.03M-16.07M-27.31M5.69M-3.86M3.56M-10.43M3.86M-2.77M102.77M-16.75M-11.53M52.66M-9.46M-82.72M-15.26M-11.16M9.21M60.30M
Free Cash Flow (Quarter)
-18.27M-16.10M-16.07M-12.53M5.78M-4.04M-10.21M-11.03M-6.84M-2.77M-6.20M-16.28M-11.53M-15.04M-9.46M-11.34M-16.41M-14.29M-17.70M-20.00M
Net Cash Flow (Quarter)
31.27M-17.03M-16.07M-27.31M5.69M-3.86M3.56M-10.43M3.86M-2.77M102.77M-16.75M-11.53M52.66M-9.46M-82.67M-15.30M-11.20M9.20M60.28M